PharVision Advisers’s CarMax KMX Stock Holding History

PharVision Advisers’s Portfolio KMX Stock Details KMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,303	Closed	-$356K	–	730
2025 Q2	$356K	Buy	+5,303	New	+$357K	0.51%	38

Other funds holding KMX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

PharVision Advisers's KMX Position: Q3 2025 in Review

PharVision Advisers sold out of CarMax (KMX) in Q3 2025, closing a stake of 5,303 shares — an estimated $356K sold.

PharVision Advisers first reported a position in KMX in Q2 2025 and held it in 1 quarter. The position peaked at $356K in Q2 2025. 622 funds tracked by Wall St. Rank hold KMX as of Q3 2025.

PharVision Advisers reported no remaining CarMax position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 5,303 CarMax shares in Q3 2025, an estimated $356K.
PharVision Advisers first reported a position in CarMax in Q2 2025 and held it in 1 quarter.
PharVision Advisers's CarMax position peaked at $356K in Q2 2025.
622 funds tracked by Wall St. Rank held CarMax as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.